Cargando…

The Inhibition of Folylpolyglutamate Synthetase (folC) in the Prevention of Drug Resistance in Mycobacterium tuberculosis by Traditional Chinese Medicine

Tuberculosis (TB) is an infectious disease caused by many strains of mycobacteria, but commonly Mycobacterium tuberculosis. As a possible method of reducing the drug resistance of M. tuberculosis, this research investigates the inhibition of Folylpolyglutamate synthetase, a protein transcript from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Tzu-Chieh, Chen, Kuen-Bao, Lee, Wen-Yuan, Chen, Calvin Yu-Chian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090511/ https://www.ncbi.nlm.nih.gov/pubmed/25050369 http://dx.doi.org/10.1155/2014/635152

Ejemplares similares

Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis
por: Wang, Ruiqi, et al.
Publicado: (2021)

Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains
por: Wei, Wenjing, et al.
Publicado: (2019)

FolC2‐mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri
por: Thomas, Carissa M., et al.
Publicado: (2016)

Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations
por: Wang, Wei, et al.
Publicado: (2022)

Lead Screening for CXCR4 of the Human HIV Infection Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Investigation of Potent Lead for Acquired Immunodeficiency Syndrome from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

An Investigation of Small GTPases in relation to Liver Tumorigenesis Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Structures of Mycobacterium tuberculosis folylpolyglutamate synthase complexed with ADP and AMPPCP
por: Young, Paul G., et al.
Publicado: (2008)

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer's Disease
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Possible Inhibitor from Traditional Chinese Medicine for the β Form of Calcium-Dependent Protein Kinase Type II in the Treatment of Major Depressive Disorder
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Arabidopsis Plastidial Folylpolyglutamate Synthetase Is Required for Seed Reserve Accumulation and Seedling Establishment in Darkness
por: Meng, Hongyan, et al.
Publicado: (2014)

Treatment of Cardiovascular Disease by Traditional Chinese Medicine against Pregnane X Receptor
por: Chen, Kuen-Bao, et al.
Publicado: (2014)

Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia
por: Huang, Zhen, et al.
Publicado: (2016)

Loss of function of folylpolyglutamate synthetase 1 reduces lignin content and improves cell wall digestibility in Arabidopsis
por: Srivastava, Avinash C., et al.
Publicado: (2015)

In Silico Investigation of Potential Pyruvate Kinase M2 Regulators from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
por: Muller, Ittai B, et al.
Publicado: (2020)

The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice.
por: Walton, M. I., et al.
Publicado: (1998)

Silencing Folylpolyglutamate Synthetase1 (FPGS1) in Switchgrass (Panicum virgatum L.) Improves Lignocellulosic Biofuel Production
por: Mazarei, Mitra, et al.
Publicado: (2020)

Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Ligand-Based and Structure-Based Investigation for Alzheimer's Disease from Traditional Chinese Medicine
por: Liao, Kai Hsin, et al.
Publicado: (2014)

Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Inactivation of folylpolyglutamate synthetase Met7 results in genome instability driven by an increased dUTP/dTTP ratio
por: Schmidt, Tobias T, et al.
Publicado: (2020)

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014)

Treatment of Acute Lymphoblastic Leukemia from Traditional Chinese Medicine
por: Hsiao, Ya-Li, et al.
Publicado: (2014)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

Pharmacological Chaperone Design for Reducing Risk Factor of Parkinson's Disease from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

In Silico Investigation of Potential Src Kinase Ligands from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2012)

Lead Discovery for Alzheimer's Disease Related Target Protein RbAp48 from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

When Modern Technology Meets Ancient Traditional Chinese Medicine
por: Chen, Calvin Yu-Chian, et al.
Publicado: (2015)

Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation
por: Tang, Hsin-Chieh, et al.
Publicado: (2015)

In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Computational Design of Apolipoprotein E4 Inhibitors for Alzheimer's Disease Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
por: Tsou, Yung-An, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_afr19faqopl25attjeuo07ujq4